Menu
GeneBe

NR1I2

nuclear receptor subfamily 1 group I member 2, the group of Nuclear receptor subfamily 1 group I

Basic information

Region (hg38): 3:119780483-119818487

Links

ENSG00000144852NCBI:8856OMIM:603065HGNC:7968Uniprot:O75469AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NR1I2 gene.

  • Inborn genetic diseases (21 variants)
  • not provided (8 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NR1I2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
5
clinvar
7
missense
19
clinvar
2
clinvar
21
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 19 4 5

Variants in NR1I2

This is a list of pathogenic ClinVar variants found in the NR1I2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-119807296-C-T not specified Likely benign (May 31, 2022)2293385
3-119807328-G-T not specified Uncertain significance (Jan 04, 2024)3201899
3-119807341-G-A not specified Uncertain significance (Dec 16, 2023)3201900
3-119807374-C-T not specified Uncertain significance (Nov 22, 2023)3201894
3-119807428-G-A not specified Uncertain significance (Jan 26, 2023)2457186
3-119810111-C-A not specified Uncertain significance (Nov 30, 2022)2221587
3-119810161-C-T not specified Uncertain significance (Feb 02, 2022)2207300
3-119810178-C-T Benign (Jun 29, 2018)773133
3-119811553-G-A not specified Uncertain significance (Sep 13, 2023)2589526
3-119811559-G-A not specified Uncertain significance (Apr 20, 2023)2511315
3-119811576-C-T Benign (Mar 29, 2018)710422
3-119811586-C-T not specified Uncertain significance (Oct 03, 2023)3201896
3-119811608-G-C not specified Uncertain significance (Dec 15, 2022)2207698
3-119811644-A-G not specified Uncertain significance (Jun 24, 2022)2297011
3-119811691-T-G not specified Uncertain significance (Jan 22, 2024)3201897
3-119811699-T-C Benign (Aug 29, 2018)775899
3-119812709-C-T Likely benign (May 01, 2022)2654059
3-119812713-G-A not specified Uncertain significance (Oct 26, 2021)2379440
3-119812774-G-A not specified Uncertain significance (Dec 07, 2021)2408368
3-119812794-A-G not specified Uncertain significance (Jan 24, 2024)3201898
3-119812813-G-A not specified Uncertain significance (Mar 21, 2022)2405177
3-119812847-C-A Likely benign (Jun 13, 2018)726853
3-119812862-C-T Benign (Jul 21, 2018)787169
3-119812953-T-C not specified Likely benign (Dec 01, 2022)2377653
3-119812954-A-G not specified Uncertain significance (Aug 16, 2022)2369737

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NR1I2protein_codingprotein_codingENST00000337940 938002
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.27e-90.4591256850631257480.000251
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.6223072781.100.00001753115
Missense in Polyphen121106.41.13721234
Synonymous-1.061211071.130.00000663911
Loss of Function0.9751519.70.7639.03e-7245

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007080.000704
Ashkenazi Jewish0.000.00
East Asian0.0005440.000544
Finnish0.0001860.000185
European (Non-Finnish)0.0002040.000202
Middle Eastern0.0005440.000544
South Asian0.0003950.000392
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Nuclear receptor that binds and is activated by variety of endogenous and xenobiotic compounds. Transcription factor that activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs and endogenous compounds. Activated by the antibiotic rifampicin and various plant metabolites, such as hyperforin, guggulipid, colupulone, and isoflavones. Response to specific ligands is species-specific. Activated by naturally occurring steroids, such as pregnenolone and progesterone. Binds to a response element in the promoters of the CYP3A4 and ABCB1/MDR1 genes. {ECO:0000269|PubMed:11297522, ECO:0000269|PubMed:11668216, ECO:0000269|PubMed:12578355, ECO:0000269|PubMed:18768384, ECO:0000269|PubMed:19297428, ECO:0000269|PubMed:9727070}.;
Pathway
Carbamazepine Pathway, Pharmacokinetics;Taxane Pathway, Pharmacokinetics;Metformin Pathway, Pharmacodynamic;Etoposide Pathway, Pharmacokinetics/Pharmacodynamics;NHR;Nuclear Receptors;Drug Induction of Bile Acid Pathway;Pregnane X Receptor pathway;Glucocorticoid Receptor Pathway;Nuclear Receptors Meta-Pathway;Nuclear Receptors in Lipid Metabolism and Toxicity;Gene expression (Transcription);Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription (Consensus)

Recessive Scores

pRec
0.650

Intolerance Scores

loftool
rvis_EVS
-0.55
rvis_percentile_EVS
19.86

Haploinsufficiency Scores

pHI
0.452
hipred
N
hipred_score
0.354
ghis
0.438

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.996

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nr1i2
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
transcription initiation from RNA polymerase II promoter;xenobiotic metabolic process;signal transduction;multicellular organism development;steroid metabolic process;cell differentiation;intracellular receptor signaling pathway;exogenous drug catabolic process;xenobiotic transport;steroid hormone mediated signaling pathway;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;drug export
Cellular component
nucleus;nucleoplasm;nuclear body;intermediate filament cytoskeleton;RNA polymerase II transcription factor complex
Molecular function
transcription regulatory region sequence-specific DNA binding;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;steroid hormone receptor activity;transcription coactivator activity;nuclear receptor activity;protein binding;transcription factor binding;drug binding;zinc ion binding;nuclear receptor transcription coactivator activity;signaling receptor activity